Abstract
Introduction
Recently, automated detection has been a new approach to address the risks posed by prescribing errors. This study focused on prescription errors and utilized real medical data to supplement the Drug Utilization Review (DUR)-based rules, the current prescription error detection method. We developed a new hybrid method through artificial intelligence for prescription error prediction by utilizing actual detection accuracy improvement to reduce ‘warning fatigue’ for doctors and improve medical care quality.
Object
This study was conducted in the Department of Pediatrics, targeting children sensitive to drugs to develop a prescription error detection system. Based on the DUR prescription history, 15,281 patient-level observations of children from Konyang University Hospital (KYUH)’s common data model (CDM) and DUR were collected and analyzed retrospectively.
Method
Among the CDM data, inspection information was interlocked with DUR and reflected as standard information for model development; this included outpatient prescriptions from January 1 to December 31, 2018. Through consultation with pediatric clinicians, rule definitions and model development were conducted for 35 drugs, with 137,802 normal and 1609 prescription errors.
Results
We developed a novel hybrid method of error detection in the form of an advanced rule-based deep neural network (ARDNN), which showed the expected performance (precision: 72.86, recall: 81.01, F1 score: 76.72) and reduced alarm pop-up alert fatigue to below 10%. We also created an ARDNN-based comprehensive dashboard that allows doctors to monitor prescription errors with alarm pop-ups when prescribing medications.
Conclusion
These results can advance the existing rule-based model by developing a prescription error detection model using deep learning. This method can improve overall medical efficiency and service quality by reducing doctors’ fatigue.
Similar content being viewed by others
References
Donaldson MS, Corrigan JM, Kohn LT, editors. To err is human: building a safer health system. National Academies Press; 2000.
Andel C, Davidow SL, Hollander M, Moreno DA. The economics of health care quality and medical errors. J Health Care Fin. 2012;39(1):39–50.
Leviatan I, Oberman B, Zimlichman E, Stein GY. Associations of physicians’ prescribing experience, work hours, and workload with prescription errors. J Am Med Inform Assoc. 2020. https://doi.org/10.1093/jamia/ocaa219.
Osheroff J, et al. Improving Outcomes with Clinical Decision Support: An Implementer’s Guide. HIMSS Publishing; 2012.
Berner ES, La Lande TJ. Overview of clinical decision support systems. In: Clinical decision support systems. New York: Springer; 2007. p. 3–22.
Anooj PK. Clinical decision support system: risk level prediction of heart disease using weighted fuzzy rules. J King Saud Univ Comput Inf Sci. 2012;24(1):27–40.
Segal G, Segev A, Brom A, Lifshitz Y, Wasserstrum Y, Zimlichman E. Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning-based clinical decision support system in an inpatient setting. J Am Med Inform Assoc. 2019;26(12):1560–5. https://doi.org/10.1093/jamia/ocz135.
Medaware: Transforming Patient Safety. MedAware. Available: https://www.medaware.com/. Accessed December 3, 2020.
Prada SI, Loaiza JS. Comparing the medicaid prospective drug utilization review program cost-savings methods used by state agencies in 2015 and 2016. Am Health Drug Benefits. 2019;12(1):7–12.
Lipton HL, Bird JA. Drug utilization review in ambulatory settings: state of the science and directions for outcomes research. Med Care. 1993;31:1069–82. https://doi.org/10.1097/00005650-199312000-00001.
Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. J Artif Intel Res. 2002;16:321–57. https://doi.org/10.1613/jair.953.
Kubat M, et al. Addressing the curse of imbalanced training sets: one-sided selection. ICML; 1997. p. 179–86.
Liang Z, et al. Deep learning for healthcare decision making with EMRs. 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2014. Doi: https://doi.org/10.1109/BIBM.2014.6999219.
Rozenblum R, Rodriguez-Monguio R, Volk LA, Forsythe KJ, McGurrin WDH, et al. Using a machine learning system to identify and prevent medication prescribing errors: a clinical and cost analysis evaluation. J Qual Patient Saf. 2020;46(1):3–10. https://doi.org/10.1016/j.jcjq.2019.09.008.
Fulda TR, Lyles A, Pugh MC, Christensen DB. Current status of prospective drug utilization review. J Manag Care Pharm. 2004;10(5):433–41. https://doi.org/10.18553/jmcp.2004.10.5.433.
Lee S-M, Lee S-O, Kim D-S. Physicians’ and pharmacists’ perceptions on real-time drug utilization review system: a nationwide survey. Int J Qual Health Care. 2017;29(5):634–41. https://doi.org/10.1093/intqhc/mzx085.
Wilson DG, McArtney RG, Newcombe RG, McArtney RJ, Gracie J, Kirk CR, et al. Medication errors in pediatric practice: insights from a continuous quality improvement approach. Eur J Pediatr. 1998;157(9):769–74. https://doi.org/10.1007/s004310050932.
Cohen MR, Senders J, Davis NM. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm. 1994;29(4):319–30.
Christopoulou F, et al. Adverse drug events and medication relation extraction in electronic health records with ensemble deep learning methods. J Am Med Inf Assoc. 2020;27:39–46. https://doi.org/10.1093/jamia/ocz101.
Ting H-W, Chung SL, Chen CF, Chiu HY, Hsieh YW. A drug identification model developed using deep learning technologies: experience of a medical center in Taiwan. BMC Health Serv Res. 2020;20:312. https://doi.org/10.1186/s12913-020-05166-w.
Corny J, Rajkumar A, Martin O, Dode X, Lajonchère JP, Billuart O, et al. A machine learning-based clinical decision support system to identify prescriptions with a high risk of medication error. J Am Med Inform Assoc. 2020;27(11):1688–94. https://doi.org/10.1093/jamia/ocaa154.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Author contributions
All authors contributed to the manuscript conception and design. All authors read and approved the final manuscript. Conceptualization, JS, JY, YK, SL and J-YK; Funding acquisition, J-YK; Data curation, Formal analysis and Methodology, JS, HSK and MJL; Project administration, SL and SL; Resources, JMY; Supervision, J-YK; Investigation, Writing—original draft, review & editing, SL, SL, SL and J-YK.
Funding
This research was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant number: HI17C2412) and by the National IT Industry Promotion Agency (NIPA) Grant funded by the Korean government (MSIT) (No. A0105-20-1008, Development of AI-based detection service for prescription errors).
Data availability
The dataset used and analyzed during this study are not publicly available due to privacy or ethical restrictions.
Conflicts of interest
The authors declare no conflict of interest.
Ethics approval
This study was approved by the Institutional Review Board (IRB) of KYUH (IRB number : 2019-06-013-009).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Code availability
Not applicable.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lee, S., Shin, J., Kim, H.S. et al. Hybrid Method Incorporating a Rule-Based Approach and Deep Learning for Prescription Error Prediction. Drug Saf 45, 27–35 (2022). https://doi.org/10.1007/s40264-021-01123-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40264-021-01123-6